A graphic of a finger touching an interactive screen

With the rise of digital technologies, there are more data available than ever before. Healthcare is no exception. And not only are there more data, but they are coming from different places. Alongside the more traditional sources such as government, healthcare systems and academia, data are being churned out from medical devices, mobile apps and websites.

We need to be able to link up and consolidate these increasingly complex data, and turn them into useful information that can improve healthcare and inform policy, both locally and globally.

We were established in response to this need. We’re a strategic unit within the Institute of Global Health Innovation that aims to enhance patient care through a more effective use of health data. Our hub gathers, houses, interprets, and analyses health datasets, to make impactful discoveries about both individual people and whole populations. It also ensures that the data is stored and managed appropriately, in compliance with data protection regulations.

Our work

We use data science and analytics to answer big questions: Are we performing as well as other healthcare systems? How can we generate national approaches to disease prevention? How best can we use genetic data to make medicine more personalised?

These are just a few of the areas our team is interested in. Find out more about some of the work our researchers are doing to use data to influence policy and improve healthcare.

Find out more about our work

COVID-19 behaviour tracker

Two people wearing face masks

In April 2020 we began tracking how people were responding to the coronavirus pandemic across 29 countries, areas or territories. Data from our global survey, run in partnership with YouGov, are made freely available through an open data dashboard, policy reports and GitHub (for more information see IGHI's response to COVID-19.)

As part of this project, we have partnered with the co-editors of the World Happiness Report, published by the UN Sustainable Development Solutions Network, to explore life satisfaction during COVID-19. We also acknowledge the contribution from the World Health Organization working group on measuring behavioural and social drivers (BeSD) of COVID-19 vaccination.

Data from the COVID-19 Behaviour Tracker have been used in a number of academic publications. A recent paper by our team found that vaccine hesitancy decreased considerably between November 2020 and January 2021 across surveyed countries. 

The project was led by Sarah P Jones, IGHI doctoral researcher, Melanie Leis, Director of Policy and Analysis at the Centre for Health Policy, and Gianluca Fontana, Deputy Director of IGHI.

We’re grateful to our collaborators from the World Happiness Report, who are leading the analysis on life satisfaction levels: Professor John F Helliwell, Professor Jeffrey D Sachs, Professor the Lord Richard Layard, and Associate Professor Jan-Emmanuel De Neve.

Our progress

A man filling in a feedback form

Listen, learn, improve

Patients’ feedback on their experience of care is a hugely valuable resource that could guide measures to improve care quality. But it’s been largely untapped as free text is difficult to analyse en masse and extract meaningful insights from.

Our researchers have used a technique called Natural Language Processing to crunch huge swathes of feedback and gain a greater understanding of patient experience. This transformative project won a BMJ Award for Digital Innovation and could lead to new measures to improve the quality of healthcare.

Determining the true cost of sickness

With an ageing population and rising levels of obesity, more and more people in the UK are living with more than one health condition (multimorbidity). We’ve been working with the Business School to facilitate their research that’s examining the financial impact of multimorbidity on health systems.

This research combined primary and secondary care data to look at the impact and costs of having more than one non-communicable (can't be passed on) disease, compared with having one illness. The work involved more than 1 million patients and forms part of a trans-European study that’s comparing the cost of illness across the continent, helping us to better understand the economic burden of disease and inform future strategies that could mitigate these rising costs.

Contact us

If you’re interested in finding out more about our work or collaborating with us, get in touch with:

Melanie Leis
Director of Policy and Analysis
Centre for Health Policy
Institute of Global Health Innovation